{"hands_on_practices": [{"introduction": "Controlling the initial conditions of a phage-bacteria interaction is fundamental to any therapeutic strategy. The Multiplicity of Infection (MOI), defined as the ratio of phage particles to bacterial cells, is the most critical parameter to set for an experiment. This exercise will guide you through the essential calculation for preparing an experiment with a precise MOI, a foundational skill for ensuring reproducible and effective phage-based treatments [@problem_id:2034379].", "problem": "In a synthetic biology laboratory, a researcher is preparing an experiment for phage therapy, a promising alternative to antibiotics. The protocol requires infecting a bacterial culture with a precise ratio of bacteriophages (phages) to bacteria. This ratio is known as the Multiplicity of Infection (MOI), defined as the number of infectious phage particles per host cell.\n\nThe researcher has a bacterial culture with a volume $V_{c} = 0.50$ mL. The concentration of viable bacteria in this culture has been determined to be $C_{b} = 5.0 \\times 10^{8}$ Colony-Forming Units per milliliter (CFU/mL). A highly concentrated stock solution of engineered bacteriophages is available, with a titer of $C_{p} = 1.0 \\times 10^{12}$ Plaque-Forming Units per milliliter (PFU/mL).\n\nTo ensure effective infection for the experiment, a target MOI of 5.0 must be achieved. Calculate the volume of the phage stock solution that must be added to the bacterial culture to reach this target MOI.\n\nExpress your answer in microliters (Î¼L), rounded to two significant figures.", "solution": "The target multiplicity of infection (MOI) is defined as the ratio of infectious phage particles added to the number of host cells present:\n$$\n\\text{MOI}=\\frac{N_{p}}{N_{b}},\n$$\nwhere $N_{p}$ is the number of phage particles to add and $N_{b}$ is the number of bacterial cells in the culture. To achieve a target MOI, set\n$$\nN_{p}=\\text{MOI}_{t}\\,N_{b}.\n$$\nThe number of bacteria present is given by the product of their concentration and the culture volume:\n$$\nN_{b}=C_{b}\\,V_{c}.\n$$\nThe volume of phage stock to add is the required number of phage particles divided by the stock titer:\n$$\nV_{p}=\\frac{N_{p}}{C_{p}}=\\frac{\\text{MOI}_{t}\\,C_{b}\\,V_{c}}{C_{p}}.\n$$\nSubstituting the given values $V_{c}=0.50\\ \\text{mL}$, $C_{b}=5.0\\times 10^{8}\\ \\text{CFU/mL}$, $C_{p}=1.0\\times 10^{12}\\ \\text{PFU/mL}$, and $\\text{MOI}_{t}=5.0$:\n$$\nN_{b}=5.0\\times 10^{8}\\times 0.50=2.5\\times 10^{8},\n$$\n$$\nN_{p}=5.0\\times 2.5\\times 10^{8}=1.25\\times 10^{9},\n$$\n$$\nV_{p}=\\frac{1.25\\times 10^{9}}{1.0\\times 10^{12}}=1.25\\times 10^{-3}\\ \\text{mL}.\n$$\nConvert milliliters to microliters using $1\\ \\text{mL}=10^{3}\\ \\mu\\text{L}$:\n$$\nV_{p}=1.25\\times 10^{-3}\\times 10^{3}=1.25\\ \\mu\\text{L}.\n$$\nRounded to two significant figures, the required volume is $1.3\\ \\mu\\text{L}$. Per the instruction to report only the numerical value in microliters, the final answer is $1.3$.", "answer": "$$\\boxed{1.3}$$", "id": "2034379"}, {"introduction": "Once a lytic phage successfully infects a host, its primary objective is to replicate. The burst size quantifies this success, representing the number of new phage progeny released upon cell lysis. This parameter is a key determinant of a phage's therapeutic potential, as a large burst size enables the phage population to rapidly overwhelm a bacterial infection. This practice explores the direct relationship between the initial number of infected cells and the total phage yield in a single, idealized lytic cycle [@problem_id:2034352].", "problem": "In a synthetic biology laboratory, researchers are optimizing a therapeutic bacteriophage, named PhagoKill-MRSA, designed to combat multi-drug resistant *Staphylococcus aureus*. A culture containing a total of $N_{bac} = 4.0 \\times 10^7$ viable and susceptible bacterial cells is prepared. To initiate a lytic infection, a concentrated stock of PhagoKill-MRSA is added to the bacterial culture to achieve a Multiplicity of Infection (MOI) of 15. The MOI is defined as the ratio of infectious phage particles to susceptible bacterial cells. The engineered phage has a known burst size, $B$, of 85 new virions per successfully infected and lysed host cell. Assuming that the infection is perfectly synchronized, that every bacterial cell becomes infected and undergoes lysis in this single cycle, and that the latent period is sufficient for phage replication, calculate the total number of new phage virions produced in this single lytic cycle.\n\nProvide your answer in scientific notation, rounded to three significant figures.", "solution": "Let $N_{\\text{bac}}$ be the number of susceptible bacterial cells, MOI the multiplicity of infection, and $B$ the burst size (new virions produced per successfully infected and lysed cell).\n\nBy definition of MOI, the number of infectious phage particles added is\n$$\nN_{\\text{phage}}^{(0)}=\\text{MOI}\\cdot N_{\\text{bac}}.\n$$\nWith $\\text{MOI}=15$ and $N_{\\text{bac}}=4.0\\times 10^{7}$, this gives\n$$\nN_{\\text{phage}}^{(0)}=15\\times\\left(4.0\\times 10^{7}\\right)=6.0\\times 10^{8}.\n$$\nGiven the assumption of perfectly synchronized infection in which every bacterial cell is infected and undergoes lysis in a single cycle, the number of successfully infected cells is\n$$\nN_{\\text{infected}}=N_{\\text{bac}}.\n$$\nThe total number of new virions produced in this lytic cycle is given by the burst-size relation\n$$\nN_{\\text{new}}=B\\cdot N_{\\text{infected}}.\n$$\nSubstituting $B=85$ and $N_{\\text{infected}}=4.0\\times 10^{7}$,\n$$\nN_{\\text{new}}=85\\times\\left(4.0\\times 10^{7}\\right)=340\\times 10^{7}=3.40\\times 10^{9}.\n$$\nExpressed in scientific notation to three significant figures, the total number of new phage virions produced is $3.40\\times 10^{9}$.", "answer": "$$\\boxed{3.40 \\times 10^{9}}$$", "id": "2034352"}, {"introduction": "A cornerstone of engineering therapeutic phages is the ability to redirect their specificity to target pathogenic bacteria. After modifying a phage's host-recognition machinery, such as its tail fibers, it is crucial to quantitatively assess the success of the engineering effort. This problem introduces a practical method for evaluating engineered phage variants by comparing their infectivity on the new target pathogen versus the original host, allowing you to identify the most promising candidate for therapeutic development [@problem_id:2034397].", "problem": "A synthetic biology team is developing engineered bacteriophages for therapeutic use against a pathogenic bacterial strain, `Strain-R`, which has developed widespread antibiotic resistance. The original, wild-type phage, `Phage-WT`, is highly effective at infecting a non-pathogenic laboratory host, `Strain-S`, but shows negligible activity against `Strain-R`. The engineering strategy focuses on modifying the phage's tail fiber proteins to switch its host preference from `Strain-S` to `Strain-R`.\n\nAfter performing genetic modifications, the team has produced three promising engineered variants: `Phage-E1`, `Phage-E2`, and `Phage-E3`. To evaluate their success, they conduct quantitative plaque assays. This involves preparing separate agar plates with a uniform lawn of each bacterial strain (`Strain-S` and `Strain-R`) and then applying serial dilutions of each phage stock to determine the concentration of infectious particles. This concentration, or titer, is measured in Plaque-Forming Units per milliliter (PFU/mL). The experimental results are summarized below:\n\n| Phage Variant | Titer on Strain-S (PFU/mL) | Titer on Strain-R (PFU/mL) |\n| :------------ | :--------------------------- | :--------------------------- |\n| Phage-WT      | $2.50 \\times 10^8$           | $1.25 \\times 10^2$           |\n| Phage-E1      | $1.80 \\times 10^8$           | $7.50 \\times 10^5$           |\n| Phage-E2      | $3.75 \\times 10^3$           | $1.60 \\times 10^8$           |\n| Phage-E3      | $9.20 \\times 10^6$           | $8.80 \\times 10^7$           |\n\nTo quantify the effectiveness of the host-switching modification, the team defines a \"Host-Switching Efficacy\" (HSE) metric for each phage. The HSE is calculated as the ratio of the phage's titer on the target strain (`Strain-R`) to its titer on the original host strain (`Strain-S`). A higher HSE value signifies a more successful and desirable switch in host specificity, indicating high infectivity on the target pathogen and low residual infectivity on the original non-pathogenic host.\n\nYour task is to identify which of the three engineered variants (`Phage-E1`, `Phage-E2`, or `Phage-E3`) is the most successful candidate based on this criterion, and to calculate its corresponding HSE value. Report this maximum HSE value, rounded to three significant figures.", "solution": "The Host-Switching Efficacy (HSE) is defined for each phage as the ratio of its titer on the target strain to its titer on the original host strain:\n$$\\mathrm{HSE}=\\frac{T_{\\mathrm{R}}}{T_{\\mathrm{S}}}.$$\nCompute HSE for each engineered variant using the provided titers.\n\nFor Phage-E1:\n$$\\mathrm{HSE}_{\\mathrm{E1}}=\\frac{7.50 \\times 10^{5}}{1.80 \\times 10^{8}}=\\frac{7.50}{1.80} \\times 10^{5-8}=\\frac{25}{6} \\times 10^{-3}\\approx 4.166\\ldots \\times 10^{-3}.$$\n\nFor Phage-E2:\n$$\\mathrm{HSE}_{\\mathrm{E2}}=\\frac{1.60 \\times 10^{8}}{3.75 \\times 10^{3}}=\\frac{1.60}{3.75} \\times 10^{5}=\\frac{32}{75} \\times 10^{5}=\\frac{3200000}{75}=42666.\\overline{6}\\approx 4.266\\ldots \\times 10^{4}.$$\n\nFor Phage-E3:\n$$\\mathrm{HSE}_{\\mathrm{E3}}=\\frac{8.80 \\times 10^{7}}{9.20 \\times 10^{6}}=\\frac{8.80}{9.20} \\times 10^{1}=\\frac{88}{92} \\times 10^{1}=\\frac{22}{23} \\times 10^{1}=\\frac{220}{23}\\approx 9.565217\\ldots.$$\n\nSince a higher HSE indicates a more successful host switch, compare the values:\n$$\\mathrm{HSE}_{\\mathrm{E1}}\\approx 4.166\\ldots \\times 10^{-3},\\quad \\mathrm{HSE}_{\\mathrm{E2}}\\approx 4.266\\ldots \\times 10^{4},\\quad \\mathrm{HSE}_{\\mathrm{E3}}\\approx 9.565\\ldots.$$\nThe maximum is for Phage-E2. Rounding to three significant figures gives:\n$$\\mathrm{HSE}_{\\mathrm{E2}} \\approx 4.27 \\times 10^{4}.$$", "answer": "$$\\boxed{4.27 \\times 10^{4}}$$", "id": "2034397"}]}